Mammogen
PrivateLast Round
Series A
Jun 3, 2026
Total Funding Raised
$33M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Mammogen is a biotechnology company that develops RNA-powered molecular diagnostic devices designed to improve the detection, diagnosis, and treatment of women's health-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mammogen Comparables
Compare Mammogen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astrin Biosciences | 90% | |
| Syantra Inc. | 85% | |
| OncoTAb | 81% |
Mammogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 3, 2026 | ||||
| Seed | Jun 30, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 6247% MoM, from 15 to 952.
- Jun 3, 2026
$30M round completed.
Recent news
Latest coverage and updates
- hiresJun 24, 2026
Mammogen hired Elise Berman as Chief Medical Officer on Jun 24th '26.
Mammogen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mammogen's valuation, stock price, and market status.
Is Mammogen a public or private company?
Mammogen is a private company.
What is the current stock price of Mammogen?
Mammogen is a private company with no public stock price. No recent secondary market data is available.
How much is Mammogen worth (valuation)?
Valuation information for Mammogen is not publicly available.
Can I buy Mammogen stock?
Mammogen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mammogen's last funding round?
Mammogen's most recent funding round was Series A on June 3, 2026.
Who are the main investors in Mammogen?
Investor information for Mammogen is not publicly disclosed.
Will Mammogen IPO soon?
No public IPO plans have been announced for Mammogen.
How can I track Mammogen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mammogen's secondary market activity and sign up for updates.